Showing results (71-80 of 172) with videos related to
Sort By:
Pageof 18
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in adjuvant with PF-3512676 and GM-CSF in metastatic melanomaAhmad A Tarhini, Siyang Leng, Stergios J Moschos, et al.Journal for Immunotherapy of Cancer|August 16, 2022
Neoadjuvant immunotherapy of locoregionally advanced solid tumorsAhmad A Tarhini, Jennifer R Eads, Kathleen N Moore, et al.Melanoma Research|December 2, 2021
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitorsCharlene M Mantia, Lillian Werner, Brian Stwalley, et al.Translational Oncology|January 15, 2021
Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanomaArjun Khunger, Ghanashyam Sarikonda, Jennifer Tsau, et al.Journal for Immunotherapy of Cancer|September 25, 2019
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014Janice P Dutcher, Douglas J Schwartzentruber, Howard L Kaufman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Next generation of immunotherapy for melanomaJohn M Kirkwood, Ahmad A Tarhini, Monica C Panelli, et al.Anticancer Research|October 15, 2013
Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancerAhmad A Tarhini, Haris Zahoor, Brian McLaughlin, et al.British Journal of Cancer|August 4, 2011
Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumoursH A Tawbi, L Villaruz, A Tarhini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanomaAhmad A Tarhini, John Cherian, Stergios J Moschos, et al.Journal of Translational Medicine|October 1, 2015
Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanomaAhmad A Tarhini, Haris Zahoor, Jennifer H Yearley, et al.Pageof 18